NCT06283745View on ClinicalTrials.gov

Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 23, 2024

Primary Completion Date

March 22, 2027

Study Completion Date

March 22, 2027

Conditions
Paraosmia
Interventions
OTHER

Platelet-rich Plasma (PRP)

Platelet-rich plasma (PRP) intranasal injection in the treatment of qualitative olfactory dysfunction (parosmia). This is taken from a blog draw from the patient themselves, and thus no external drug/biologic product will be given - only the concentrated plasma portion from the patient's own blood.

OTHER

Saline

Saline intranasal injection (sham injection)

Trial Locations (1)

94304

RECRUITING

Stanford Sinus Center / Stanford University School of Medicine, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER